MRK vs HCA
By Alex · Tickerpine
Merck & Co., Inc. vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HCA |
|---|---|---|
| Price | $147.76 | $499.05 |
| Market cap | $364.26B | $104.25B |
| P/E ratio | 149.3 | 16.6 |
| ROE | 5.06% | — |
| Profit margin | 3.64% | 8.61% |
| Revenue growth | 4.70% | 3.60% |
| Dividend yield | 2.30% | 0.63% |
| Beta | 0.12 | 1.10 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HCA in plain English
- MRK is the bigger company — about 3.5× the market cap of HCA.
- HCA is cheaper on earnings (P/E 16.6 vs 149.3).
- MRK is growing revenue faster (5% vs 4%).
- MRK has the higher dividend yield (2.30% vs 0.63%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.